ArticleFrontiers in immunology2023

Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-α-accelerated lupus nephritis in mice.

Kuan-Ju Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.